DE3782652D1 - Zubereitung zum stoppen von angiogenese und einem kapillar-, zellen- oder membranleck. - Google Patents

Zubereitung zum stoppen von angiogenese und einem kapillar-, zellen- oder membranleck.

Info

Publication number
DE3782652D1
DE3782652D1 DE8787902995T DE3782652T DE3782652D1 DE 3782652 D1 DE3782652 D1 DE 3782652D1 DE 8787902995 T DE8787902995 T DE 8787902995T DE 3782652 T DE3782652 T DE 3782652T DE 3782652 D1 DE3782652 D1 DE 3782652D1
Authority
DE
Germany
Prior art keywords
capillary
cell
preparation
membrane leak
angiogenesis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE8787902995T
Other languages
English (en)
Inventor
Larrian Gillespie
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Angiogenics Ltd
Original Assignee
Angiogenics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/020,859 external-priority patent/US4820693A/en
Application filed by Angiogenics Ltd filed Critical Angiogenics Ltd
Application granted granted Critical
Publication of DE3782652D1 publication Critical patent/DE3782652D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
DE8787902995T 1986-04-04 1987-04-03 Zubereitung zum stoppen von angiogenese und einem kapillar-, zellen- oder membranleck. Expired - Lifetime DE3782652D1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US84828886A 1986-04-04 1986-04-04
US86598186A 1986-05-22 1986-05-22
US07/020,859 US4820693A (en) 1986-05-22 1987-03-02 Method and composition for arresting angiogenesis and capillary, cell or membrane leakage
PCT/US1987/000704 WO1987005808A1 (en) 1986-04-04 1987-04-03 Composition for arresting angiogenesis and capillary, cell or membrane leakage

Publications (1)

Publication Number Publication Date
DE3782652D1 true DE3782652D1 (de) 1992-12-17

Family

ID=27361529

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8787902995T Expired - Lifetime DE3782652D1 (de) 1986-04-04 1987-04-03 Zubereitung zum stoppen von angiogenese und einem kapillar-, zellen- oder membranleck.

Country Status (7)

Country Link
EP (1) EP0299975B1 (de)
AT (1) ATE82126T1 (de)
AU (1) AU600271B2 (de)
DE (1) DE3782652D1 (de)
DK (1) DK634987D0 (de)
NO (1) NO875025L (de)
WO (1) WO1987005808A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5037810A (en) * 1987-03-17 1991-08-06 Saliba Jr Michael J Medical application for heparin and related molecules
US5145841A (en) * 1987-03-19 1992-09-08 Arthropharm Pty. Limited Anti-inflammatory compounds and compositions
US5658894A (en) * 1989-04-23 1997-08-19 The Trustees Of The University Of Pennsylvania Compositions for inhibiting restenosis
US5760015A (en) * 1988-01-19 1998-06-02 The Trustees Of The University Of Pennsylvania Cyclodextrin compounds and methods of making and use thereof
US5021404A (en) * 1988-04-20 1991-06-04 The Children's Medical Center Corporation Angiostatic collagen modulators
US5605938A (en) 1991-05-31 1997-02-25 Gliatech, Inc. Methods and compositions for inhibition of cell invasion and fibrosis using dextran sulfate
BR9206736A (pt) * 1991-11-11 1995-10-31 Univ Pennsylvania Composição para afetar o crescimento de tecido vivo em mamíferos processos para promover a angiogenese em mamíferos para tratar tecido transplantado ou órgãos em mamíferos e para tratar osso danificado ou transplantado
KR102472214B1 (ko) 2018-02-28 2022-11-30 삼성전자주식회사 에어 컨디셔닝 시스템에서 복합 제어 장치 및 방법

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1226816A (en) * 1982-12-20 1987-09-15 Moses J. Folkman Inhibition of angiogenesis

Also Published As

Publication number Publication date
DK634987A (da) 1987-12-03
AU7286287A (en) 1987-10-20
EP0299975B1 (de) 1992-11-11
EP0299975A1 (de) 1989-01-25
DK634987D0 (da) 1987-12-03
ATE82126T1 (de) 1992-11-15
AU600271B2 (en) 1990-08-09
NO875025D0 (no) 1987-12-02
EP0299975A4 (de) 1989-10-25
NO875025L (no) 1987-12-02
WO1987005808A1 (en) 1987-10-08

Similar Documents

Publication Publication Date Title
NL190693C (nl) Stabiel, prostaglandine bevattend, farmaceutisch preparaat.
NO178095C (no) Fremgangsmåte for fremstilling av et omhyllet farmasöytisk retarderingspreparat
NO863916L (no) Farmasoeytiske materialer av den type som gjennomgaar en vaeske-gelefase-omdannelse.
SE8203906L (sv) Nytt bandage for administration av lekemedel
ATE8459T1 (de) Pharmazeutische zubereitung in form eines polyacrylatfilmes und deren herstellung.
DE3067536D1 (en) Powdery pharmaceutical composition and powdery preparation for application to the nasal mucosa, and method for administration thereof
NL169681C (nl) Anti-conceptisch combinatiepreparaat.
DK164482C (da) Middel i form af folier til transdermal applikation af stoffer, der er virksomme som laegemidler, samt fremgangsmaade til fremstilling heraf
DE3782652D1 (de) Zubereitung zum stoppen von angiogenese und einem kapillar-, zellen- oder membranleck.
DK324687A (da) Transdermalt farmeceutisk praeparat
IT8422785A1 (it) Derivati del benzossazolone e del benzotiazolone, procedimenti per la loro preparazione e composizione farmaceutica che li contiene
DK493386A (da) Benzimidazoler, -oxazoler og -thiazoler, deres anvendelse i farmaceutiske kompositioner og fremgangsmaade til forbindelsernes fremstilling
IT8424283A0 (it) Uso di derivati del tiofene nel trattamento dei tumori, composizioni farmaceutiche che licontengono e composti atti allo scopo.
DK69685A (da) Oralt praeparat, der indeholder allergen
DK0521057T3 (da) Farmaceutiske midler indeholdende ipriflavon, fremgangsmåde til fremstilling deraf, og relativ terapeutisk anvendelse
SE8501312D0 (sv) Etoposide oral dosage form
DK183582A (da) Fremgangsmaade til fremstilling af oxazolderivater
GB1013578A (en) Analgesic composition
SE7509607L (sv) Forfarnde for framstellning av 9,11,15-trihydroxi-13,14-dehydroprostaglandiner och prost-5-en-13-ynsyraderivat
IT8721098A0 (it) Derivati della 1-benzene solfonil 2-oco 5-alchiltio pirrolidina, un loro procedimentodi preparazione e il loro impiegocome stostanze medicinali.
DK92183A (da) 11beta-chlor-delta15-steroider, fremgangsmaade til fremstilling heraf og farmaceutiske praeparater med indhold heraf
IT7925098A0 (it) Per prepararli e composizione derivati immidazolici, procedimento farmaceutica che li contiene.
IT7822059A0 (it) Derivati della alfa-feniletilammina ad azione terapeutica, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono.
IT1051252B (it) Derivati dell etossicar binil, 3 idrossi, 5 metil, 2 pipe razinomentil, 4 indolo sostituiti, loro procedimento di preparatzione e loro applicacione in terapia
IT1167538B (it) Derivati della dregamina, procedimento per la loro preparazione, composizioni farmaceutiche che li contengono e loro impiego terapeutico

Legal Events

Date Code Title Description
8332 No legal effect for de